
1. zhonghua gan zang bing za zhi. 2018 aug 20;26(8):626-629. doi:
10.3760/cma.j.issn.1007-3418.2018.08.014.

[research progress prognostic factors hepatitis b virus-associated
end-stage liver disease].

[article chinese; abstract available chinese publisher]

feng x(1), shi xf.

author information: 
(1)second affiliated hospital chongqing medical university, chongqing 400010, 
china.

hepatitis b remains worldwide health problem high mortality rate
associated end-stage liver diseases. model end-stage liver disease
and child-pugh score still widely used prognostic model liver
cirrhosis inflammatory reaction, b-type natriuretic peptide portal vein
thrombosis independent risk factors. many new models proposed for
liver failure, including new model hinat aclf. hinat aclf better its
preceding models increased neutrophil-to-lymphocyte ratio single factor 
to promote thyroid hormone, cholinesterase, antiviral treatment response in
this model. hbv dna frequently involved predictive model liver
cancer, widespread use antiviral drugs, value long-term
prognostication gradually reduced. therefore, liver stiffness value instead
of hbv dna shows apparent advantages mreach-b. albi good median survival
prediction value hepatocellular carcinoma patients. alpha-fetoprotein and
staging method, based tumor number size, still independent
risk factors liver cancer.

publisher:
乙型肝炎目前仍是世界性健康问题，其相关终末期疾病病死率高。肝硬化的预后模型中仍以终末期肝病模型、child-pugh应用广泛，炎症反应、b型尿钠肽、门静脉血栓为独
立危险因素；肝衰竭预后中提出了新模型，其中以hinat
aclf为佳，单因素中增加了中性粒细胞/淋巴细胞比率、促甲状腺素、胆碱酯酶、抗病毒治疗的应答情况。肝癌发生的预测模型中多涉及hbv
dna，但随着抗病毒药物的普及，其在长期预后中的价值逐渐降低，因此以肝硬度值取代hbv
dna的修正慢性乙型肝炎肝细胞癌的风险评估表现出明显优势；在肝癌患者的预后中，白蛋白-胆红素指数有良好的中位生存期预测价值，甲胎蛋白、肝癌数目及大小仍为独立危险因
素。.
doi: 10.3760/cma.j.issn.1007-3418.2018.08.014 
pmid: 30317798  [indexed medline]

